Gender differences in clinical presentation and 1-year outcomes in atrial fibrillation

Heart

Volumn 103, Issue 13, 2017, Pages 1024-1030

  Schnabel, Renate B ^a   Pecen, Ladislav ^b   Ojeda, Francisco M ^a   Lucerna, Markus ^c   Rzayeva, Nargiz ^a   Blankenberg, Stefan ^a   Darius, Harald ^d   Kotecha, Dipak ^e   Caterina, Raffaele De ^f,g   Kirchhof, Paulus ^e,h  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

^c DAIICHI SANKYO CO   (Japan)

^d VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f UNIVERSITY OF CHIETI   (Italy)

^g FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^h AFNET   (Germany)

Author keywords

Atrial fibrillation; European registry; gender differences

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE CORONARY SYNDROME; ADVERSE OUTCOME; AGED; ARTERIAL THROMBOEMBOLISM; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY VEIN ISOLATION; RISK FACTOR; SEX DIFFERENCE; TRANSIENT ISCHEMIC ATTACK; AGE; CLINICAL TRIAL; COMPLICATION; EUROPE; FOLLOW UP; MULTICENTER STUDY; REGISTER; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL RATE; THROMBOEMBOLISM; TIME FACTOR; TRENDS;

AGE FACTORS; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; SURVIVAL RATE; THROMBOEMBOLISM; TIME FACTORS;

EID: 85020518220     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2016-310406     Document Type: Article

References (30)

1. C hugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837-47.
2. E mdin CA, Wong CX, Hsiao AJ, et al. Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and metaanalysis of cohort studies. BMJ 2016;532:h7013.
3. L ip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72.
4. Pancholy SB, Sharma PS, Pancholy DS, et al. Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants. Am J Cardiol 2014;113:485-90.
5. S chnabel RB, Rienstra M, Sullivan LM, et al. Risk assessment for incident heart failure in individuals with atrial fibrillation. Eur J Heart Fail 2013;15:843-9.
6. S oliman EZ, Lopez F, O'Neal WT, et al. Atrial Fibrillation and risk of ST-segmentelevation versus non-ST-segment-slevation myocardial infarction: the Atherosclerosis risk in communities (ARIC) study. Circulation 2015;131:1843-50.
7. Kirchhof P, Benussi S, Kotecha D, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur Heart J 2016;50:e1-e88.
8. Kirchhof P, Ammentorp B, Darius H, et al. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events-European Registry in Atrial Fibrillation (PREFER in AF). Europace 2014;16:6-14.
9. C amm AJ, Kirchhof P, Lip GY, et al. European Heart Rhythm Association. European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
10. Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007;9:1006-23.
11. L ip GY. Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. Am J Med 2011;124:111-4.
12. R Core Team. R: A Language and Environment for Statistical Computing. In: R Foundation for Statistical Computing. Vienna, Austria: 2016.
13. Wickham H. ggplot2. Elegant Graphics for Data Analysis. New York: Springer-Verlag, 2009.
14. Potpara TS, Marinkovic JM, Polovina MM, et al. Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. Int J Cardiol 2012;161:39-44.
15. Dagres N, Nieuwlaat R, Vardas PE, et al. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol 2007;49:572-7.
16. L ip GY, Laroche C, Boriani G, et al. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace 2015;17:24-31.
17. Boriani G, Laroche C, Diemberger I, et al. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med 2015;128:509-18.
18. C alkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm 2012;9:632-96.
19. Blomkalns AL, Chen AY, Hochman JS, et al. CRUSADE Investigators. CRUSADE Investigators. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation). J Am Coll Cardiol 2005;45:832-7.
20. S ridhar AR, Yarlagadda V, Parasa S, et al. Cardiac Resynchronization Therapy: US Trends and Disparities in Utilization and Outcomes. Circ Arrhythm Electrophysiol 2016;9:e003108.
21. Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace 2007;9:613-20.
22. Winkle RA, Mead RH, Engel G, et al. Long-term results of atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation. Am Heart J 2011;162:193-200.
23. DeWilde S, Carey IM, Emmas C, et al. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 2006;92:1064-70.
24. Vinereanu D, Stevens SR, Alexander JH, et al. Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. Eur Heart J 2015;36:3268-75.
25. A vgil Tsadok M, Jackevicius CA, Rahme E, et al. Sex differences in dabigatran use, safety, and effectiveness in a population-based cohort of patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes 2015;8:593-9.
26. H umphries KH, Kerr CR, Connolly SJ, et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation 2001;103:2365-70.
27. Friberg L, Skeppholm M, Terént A. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J Am Coll Cardiol 2015;65:225-32.
28. S oliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 2014;174:107-14.
29. C hao TF, Huang YC, Liu CJ, et al. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study. Heart Rhythm 2014;11:1941-7.
30. S oliman EZ, Safford MM, Muntner P, et al. Atrial fibrillation and the risk of myocardial infarction. JAMA Intern Med 2014;174:107-14.